PREDICTMEDIX AI INC - PMEDF STOCK NEWS

Welcome to our dedicated page for PREDICTMEDIX AI news (Ticker: PMEDF), a resource for investors and traders seeking the latest updates and insights on PREDICTMEDIX AI stock.

Predictmedix AI Inc. (PMEDF) is a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI). The company recently announced a partnership with KGK Science, a renowned name in clinical research, to advance health research and product development. This collaboration aims to introduce transformative changes in healthcare innovation, particularly in clinical trial efficiency and health product development. By leveraging Predictmedix AI's cutting-edge technologies and KGK Science's expertise, the partnership is set to redefine health assessment methodologies and outcomes.

KGK Science, with over 22 years of experience, is known for its expertise in clinical research and regulatory support for nutraceutical, cannabis, and hemp industries. On the other hand, Predictmedix AI's Safe Entry Stations utilize multispectral cameras to predict a variety of health issues, including vital parameters, drug impairment, fatigue, and mental illnesses. Together, these companies are focused on enhancing health research and product development through innovative technologies and creating impactful advancements in healthcare solutions.

09/20/2023 07:00 AM

News

Predictmedix AI Executives Departing This Weekend for Strategic Collaborations in India

Rhea-AI Summary

Predictmedix AI executives have been granted visas for a strategic visit to India to engage with institutional partners and government officials. The company aims to ensure seamless integration and scalable deployment of their contactless AI solutions, highlighting their commitment to revolutionizing healthcare and enhancing industry sectors through AI. The visit holds immense importance as it paves the way for collaboration and positive impact on healthcare and other sectors in India.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-5.48%

Tags

09/12/2023 07:00 AM

News

Predictmedix AI Showcased in Toronto Star Newspaper; Accelerates Oxygen Saturation Parameter to Accommodate Widespread Respiratory Health Issues

Rhea-AI Summary

Predictmedix AI featured in Toronto Star, highlighting their commitment to cutting-edge technology in healthcare. They have developed a Safe Entry system with 97% accuracy in contactless SPO2 measurement. This innovation has potential to revolutionize patient care and respiratory medicine in India.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

1.32%

Tags

09/06/2023 07:00 AM

News

Predictmedix AI's 2023 Breakthroughs: Pioneering Healthcare Innovation and Global Expansion

Rhea-AI Summary

Predictmedix AI achieves significant advancements in 2023, revolutionizing healthcare through cutting-edge technology, technology validations, and strategic commercialization efforts.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

08/21/2023 07:00 AM

News

Predictmedix AI Expands Diagnostic Reach in India with Innovative Diabetes Non-Invasive Screening

Rhea-AI Summary

Predictmedix AI announces the ability to detect early signs of diabetes through AI analysis, targeting India's rising diabetes concerns.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

1.35%

Tags

08/10/2023 07:00 AM

News

Enhancing Healthcare Economics: Predictmedix AI's Safe Entry Stations Revolutionize Safety and Efficiency

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

9.72%

Tags

08/02/2023 07:00 AM

News

Predictmedix AI Announces Milestone of Over 200,000 Individual Scans with AI-Powered Safe Entry Station

Rhea-AI Summary

Predictmedix AI Inc. (CSE:PMED) (OTCQB:PMEDF) (FRA:3QP) has completed over 200,000 individual scans through its AI-powered Safe Entry Stations, marking a significant milestone. The technology plays a vital role in providing seamless and secure entry to public and private establishments, as well as in triage functionality within hospital settings. The data collected from the scans has significantly advanced the company's machine learning capabilities, allowing for more precise and reliable solutions in the healthcare industry. Predictmedix AI is prepared for a commercial rollout of Safe Entry, particularly in global markets like Indonesia and India, with a strong emphasis on privacy and explicit consent for data collection.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

5.48%

Tags

07/28/2023 07:00 AM

News

Predictmedix AI Provides Update on Commercialization of Safe Entry with the Indonesian Healthcare Sector

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

5.95%

Tags

07/25/2023 07:00 AM

News

Predictmedix AI Engages in Partnership with Indian Supplier for Mass Production and Rapid Deployment of Safe Entry Stations

Rhea-AI Summary

Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) Announces Partnership for Mass Production of AI-Powered Safe Entry Stations in India

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

36.36%

Tags

07/19/2023 07:00 AM

News

Predictmedix AI Unveils Cutting-Edge Contactless Integrative AI Solutions for Healthcare in India and Incorporates Fully Owned Indian Subsidiary

Rhea-AI Summary

Predictmedix AI Inc. (CSE:PMED) Announces Contactless Integrative AI Solutions for Indian Healthcare

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

07/13/2023 07:00 AM

News

Predictmedix Inc. Announces Name Change to Predictmedix AI Inc.

Rhea-AI Summary

Predictmedix Inc. has completed its name change to Predictmedix AI Inc. The Common Shares will commence trading under the new name on or about July 17, 2023.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

FAQ

What is the current stock price of PREDICTMEDIX AI (PMEDF)?

The current stock price of PREDICTMEDIX AI (PMEDF) is $0.0095 as of October 14, 2024.

What is the market cap of PREDICTMEDIX AI (PMEDF)?

The market cap of PREDICTMEDIX AI (PMEDF) is approximately 1.8M.

What is Predictmedix AI Inc. known for?

Predictmedix AI Inc. is a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI).

Who is KGK Science and what expertise do they bring to the partnership?

KGK Science is a respected name in clinical research and regulatory consulting, offering top-tier expertise in nutraceutical, cannabis, and hemp industries.

What are the key focus areas of the partnership between Predictmedix AI Inc. and KGK Science?

The partnership aims to introduce transformative changes in healthcare innovation, particularly in clinical trial efficiency and health product development.

How do Predictmedix AI's Safe Entry Stations contribute to the partnership?

Predictmedix AI's Safe Entry Stations utilize multispectral cameras to predict various health issues, including vital parameters, drug impairment, fatigue, and mental illnesses, enhancing health research and product development.